These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 15040828
1. BMD is reduced in HIV-infected men irrespective of treatment. Amiel C, Ostertag A, Slama L, Baudoin C, N'Guyen T, Lajeunie E, Neit-Ngeilh L, Rozenbaum W, De Vernejoul MC. J Bone Miner Res; 2004 Mar; 19(3):402-9. PubMed ID: 15040828 [Abstract] [Full Text] [Related]
2. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Madeddu G, Spanu A, Solinas P, Calia GM, Lovigu C, Chessa F, Mannazzu M, Falchi A, Mura MS, Madeddu G. Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):39-48. PubMed ID: 15195003 [Abstract] [Full Text] [Related]
3. Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis. Lormeau C, Soudan B, d'Herbomez M, Pigny P, Duquesnoy B, Cortet B. Bone; 2004 Jun; 34(6):933-9. PubMed ID: 15193539 [Abstract] [Full Text] [Related]
4. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors. Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, Mehsen N, Mercié P, Morlat P, Thiébaut R, Dabis F, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. AIDS; 2008 Jan 30; 22(3):395-402. PubMed ID: 18195566 [Abstract] [Full Text] [Related]
7. [Bone mineral density in postmenopausal women with proximal femoral fractures--comparative study between quantitative ultrasonometry and gold standard DXA]. Schnabel M, Eser G, Ziller V, Mann D, Mann E, Hadji P. Zentralbl Chir; 2005 Oct 30; 130(5):469-75. PubMed ID: 16220445 [Abstract] [Full Text] [Related]
8. Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients. Seminari E, Castagna A, Soldarini A, Galli L, Fusetti G, Dorigatti F, Hasson H, Danise A, Guffanti M, Lazzarin A, Rubinacci A. HIV Med; 2005 May 30; 6(3):145-50. PubMed ID: 15876279 [Abstract] [Full Text] [Related]
11. Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study. Calmy A, Fux CA, Norris R, Vallier N, Delhumeau C, Samaras K, Hesse K, Hirschel B, Cooper DA, Carr A. J Infect Dis; 2009 Dec 01; 200(11):1746-54. PubMed ID: 19874178 [Abstract] [Full Text] [Related]
14. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV. McComsey GA, Kendall MA, Tebas P, Swindells S, Hogg E, Alston-Smith B, Suckow C, Gopalakrishnan G, Benson C, Wohl DA. AIDS; 2007 Nov 30; 21(18):2473-82. PubMed ID: 18025884 [Abstract] [Full Text] [Related]
18. Prevalence of osteoporosis in Thai men. Pongchaiyakul C, Apinyanurag C, Soontrapa S, Soontrapa S, Pongchaiyakul C, Nguyen TV, Rajatanavin R. J Med Assoc Thai; 2006 Feb 30; 89(2):160-9. PubMed ID: 16579001 [Abstract] [Full Text] [Related]
19. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status. Fahrleitner A, Prenner G, Kniepeiss D, Iberer F, Tscheliessnigg KH, Piswanger-Sölkner C, Obermayer-Pietsch B, Leb G, Dobnig H. Wien Klin Wochenschr; 2002 Aug 30; 114(15-16):717-24. PubMed ID: 12602117 [Abstract] [Full Text] [Related]